Phase IIIB Subcutaneous Abatacept Monotherapy Study

NCT00547521 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

119

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis (RA)

Interventions

DRUG: abatacept
DRUG: Methotrexate (MTX)

Sponsor

Bristol-Myers Squibb